FDA Recall D-0322-2026
F.H. INVESTMENTS, Inc. (dba Asteria Health) · Birmingham, AL
Class II Ongoing 108 days on record
Moderate impact — Class II recall — temporary or medically reversible adverse health consequence possible; remote probability of serious adverse health consequence.
Product
Testosterone, 87.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1087-32.
Reason for recall
Presence of Foreign substance - potential presence of metal particulate matter
Recall record
- Recall number
D-0322-2026- Classification
- Class II
- Status
- Ongoing
- Voluntary or mandated
- Voluntary: Firm initiated
- Firm notification
- Letter
- Distribution
- Nationwide in the USA
- Recall initiated
- 2026-01-26
- Classified by FDA Center
- 2026-02-11
- FDA published
- 2026-02-18
- Recalling firm
- F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Firm location
- Birmingham, AL
Operational response
Class II recalls indicate possible temporary or reversible health consequences. Remove affected lots from active dispensing. Segregate inventory. Check the firm’s recall notification for guidance on patient outreach.
For the official FDA enforcement record, see FDA's Recall Search.